Marcel Nijland

32PUBLICATIONS
145CO-AUTHORS
Tumour immunologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Sep 04, 2026
Treatment Patterns, Outcomes and Survival Trends in T-Cell Prolymphocytic Leukemia: A Nationwide Population-Based Study in the Netherlands.

|Aug 26, 2026
Molecular Profiling and Disease Tracking of Post-transplant Lymphoproliferative Disorders using Cell-free DNA.

|Aug 05, 2026
First-line treatment with epcoritamab in combination with bendamustine plus rituximab induces sustained remissions beyond 3 years in patients with follicular lymphoma.

|Mar 17, 2026
Immunodeficiency-associated primary CNS lymphomas: an International Primary CNS Lymphoma Collaborative Group study.

Leon D Kaulen, Lakshmi Nayak, Philipp Karschnia

|Feb 04, 2026
Impact of rituximab maintenance on survival in patients with mantle cell lymphoma: a population-based cohort study.

Floriske G Stedema, Mirian Brink, Francien Huisman

|Dec 18, 2025
Dynamics of circulating tumour DNA in relapsed/refractory diffuse large B-cell lymphoma patients.

Yujie Zhong, Johanna Bult, Nick Veltmaat

Pageof 6

Frequent Collaborators

12 joint publications

Joost Sp Vermaat

11 joint publications

Arjan Diepstra

9 joint publications

Mirian Brink

9 joint publications

Anke van den Berg